Proliferation of internal membranes in platelets from patients with Alzheimer's disease

Insights

Alzheimer's disease patients show significantly more atypical platelets with increased membrane fluidity compared to healthy individuals. This suggests a potential dysregulation in platelet membrane biosynthesis in Alzheimer's disease.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Cell Biology

Background:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
  • Platelet membrane alterations have been implicated in AD pathogenesis.
  • Previous studies suggest increased platelet membrane fluidity in AD.

Purpose of the Study:

  • To investigate ultrastructural platelet abnormalities in Alzheimer's disease.
  • To correlate platelet membrane fluidity with morphological changes in AD patients.

Main Methods:

  • Electron microscopy was used to examine platelets from AD patients and healthy controls.
  • Platelet membrane fluidity was measured using 1,6-diphenyl-1,3,5-hexatriene (DPH) fluorescence anisotropy at 37°C.

Main Results:

  • A significantly higher frequency (15.5%) of atypical platelets with abundant internal membranes was observed in AD patients compared to controls (4.6%).
  • Platelet membranes from AD patients exhibited increased fluidity, confirmed by DPH measurements.
  • Increased membrane fluidity correlated with the frequency of atypical platelets.

Conclusions:

  • The findings suggest a link between increased platelet membrane fluidity and morphological platelet abnormalities in Alzheimer's disease.
  • A dysregulation of platelet membrane biosynthesis may underlie the observed changes in AD.
  • Platelets may serve as a valuable model for studying AD-related membrane pathophysiology.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...